Trials / Unknown
UnknownNCT02306239
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
the Surgical Intensive Care Unit
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Liu ZiMeng · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the effect of terlipressin on intestinal function in septic shock patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terlipressin | |
| DRUG | Norepinephrine |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-08-01
- First posted
- 2014-12-03
- Last updated
- 2014-12-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02306239. Inclusion in this directory is not an endorsement.